Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (203) 203
life sciences & biomedicine (201) 201
humans (176) 176
respiratory system (132) 132
asthma (102) 102
male (88) 88
female (87) 87
middle aged (80) 80
aged (64) 64
general & internal medicine (61) 61
copd (59) 59
lung diseases, obstructive (59) 59
abridged index medicus (55) 55
biological and medical sciences (52) 52
medical sciences (51) 51
pulmonary disease, chronic obstructive - drug therapy (50) 50
adult (49) 49
chronic obstructive pulmonary disease (49) 49
critical care medicine (48) 48
treatment outcome (48) 48
asthma - drug therapy (47) 47
pulmonary/respiratory (47) 47
care and treatment (45) 45
allergy (36) 36
bronchodilator agents - therapeutic use (36) 36
pneumology (35) 35
quality of life (33) 33
pulmonary disease, chronic obstructive - physiopathology (32) 32
respiratory tract diseases (32) 32
risk factors (32) 32
severity of illness index (32) 32
administration, inhalation (29) 29
chronic obstructive pulmonary disease, asthma (29) 29
immunology (29) 29
analysis (27) 27
asthma - physiopathology (25) 25
drug therapy (25) 25
pulmonary disease, chronic obstructive - diagnosis (25) 25
drug therapy, combination (24) 24
double-blind method (23) 23
biomarkers (22) 22
comorbidity (22) 22
patients (22) 22
pulmonary disease, chronic obstructive - epidemiology (21) 21
anti-asthmatic agents - therapeutic use (20) 20
medical colleges (20) 20
usage (20) 20
adrenal cortex hormones - therapeutic use (19) 19
research (19) 19
bronchodilator agents - administration & dosage (18) 18
cardiac & cardiovascular systems (18) 18
cardiovascular system & cardiology (18) 18
immunoglobulin e (18) 18
mortality (18) 18
original research (18) 18
adrenergic beta-agonists - therapeutic use (17) 17
diagnosis (17) 17
pharmacology & pharmacy (17) 17
studies (17) 17
clinical medicine (16) 16
clinical trials (16) 16
disease progression (16) 16
nebulizers and vaporizers (16) 16
pharmacology. drug treatments (16) 16
depression (15) 15
forced expiratory volume (15) 15
health aspects (15) 15
pulmonary and respiratory medicine (15) 15
pulmonary disease, chronic obstructive - complications (15) 15
pulmonary disease, chronic obstructive - therapy (15) 15
spirometry (15) 15
adolescent (14) 14
anxiety (14) 14
corticosteroids (14) 14
dose-response relationship, drug (14) 14
dyspnea (14) 14
inflammation (14) 14
lung diseases (14) 14
pulmonary disease, chronic obstructive - psychology (14) 14
severe asthma (14) 14
therapy (14) 14
aged, 80 and over (13) 13
allergy and immunology (13) 13
bronchodilator agents - adverse effects (13) 13
internal medicine (13) 13
lungmedicin och allergi (13) 13
medical research (13) 13
medicine, general & internal (13) 13
phenotypes (13) 13
respiratory medicine and allergy (13) 13
safety (13) 13
dosage and administration (12) 12
forced expiratory volume - drug effects (12) 12
formoterol fumarate (12) 12
klinisk medicin (12) 12
medical and health sciences (12) 12
medicin och hälsovetenskap (12) 12
respiratory function tests (12) 12
adrenergic beta-2 receptor agonists - therapeutic use (11) 11
age (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Ipratropium Bromide HFA: A Viewpoint by Nicola A. Hanania
by Hanania, Nicola A
Treatments in respiratory medicine, ISSN 1176-3450, 2005, Volume 4, Issue 3, pp. 221 - 222
Chronic obstructive pulmonary disease | Adis Drug Profiles
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Exploring the effects of omalizumab in allergic asthma: An analysis of biomarkers in the EXTRA study
by Hanania, Nicola A and Wenzel, Sally and Roseń, Karin and Hsieh, Hsin-Ju and Mosesova, Sofia and Choy, David F and Lal, Preeti and Arron, Joseph R and Harris, Jeffrey M and Busse, William
American journal of respiratory and critical care medicine, ISSN 1073-449X, 04/2013, Volume 187, Issue 8, pp. 804 - 811
Immunoglobulin E | Fractional exhaled nitric oxide | Severe asthma | Eosinophil | Periostin | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Chronic obstructive pulmonary disease, asthma | Pneumology | Anti-Asthmatic Agents - adverse effects | Antibodies, Anti-Idiotypic - adverse effects | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Omalizumab | Male | Nitric Oxide - analysis | Young Adult | Antibodies, Anti-Idiotypic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Adult | Female | Antibodies, Anti-Idiotypic - therapeutic use | Child | Cell Adhesion Molecules - blood | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Biomarkers - analysis | Breath Tests | Asthma - drug therapy | Asthma - genetics | Disease Progression | Adolescent | Aged | Anti-Asthmatic Agents - administration & dosage | Eosinophils | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The effects of cigarette smoke on airway inflammation in asthma and COPD: Therapeutic implications
by Tamimi, Asad and Serdarevic, Dzelal and Hanania, Nicola A
Respiratory medicine, ISSN 0954-6111, 2011, Volume 106, Issue 3, pp. 319 - 328
Pulmonary/Respiratory | Therapy | Inhaled corticosteroids | Airway inflammation | Cigarette smoking | Asthma | COPD | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Toxicology | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Tobacco, tobacco smoking | Pneumology | Bronchitis - chemically induced | Bronchodilator Agents - therapeutic use | Peroxisome Proliferator-Activated Receptors - agonists | Smoking - adverse effects | Glucocorticoids - therapeutic use | Humans | Asthma - drug therapy | Forced Expiratory Volume | Asthma - immunology | Histone Deacetylase 2 - metabolism | Pulmonary Disease, Chronic Obstructive - immunology | Drug Resistance | Leukotriene Antagonists - therapeutic use | Pulmonary Disease, Chronic Obstructive - drug therapy | Enzymes | Development and progression | Inflammation | Health aspects | Theophylline | Smoking | Tobacco smoke | Drug therapy | Mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society
by Qaseem, Amir and Wilt, Timothy J and Weinberger, Steven E and Hanania, Nicola A and Criner, Gerard and van der Molen, Thys and Marciniuk, Darcy D and Denberg, Tom and Schuenemann, Holger and Wedzicha, Wisia and MacDonald, Roderick and Shekelle, Paul and European Resp Soc and Amer Thoracic Soc and Amer Coll Chest Phys and Amer Coll Phys and American College of Physicians and American Thoracic Society and American College of Chest Physicians and European Respiratory Society
Annals of internal medicine, ISSN 0003-4819, 08/2011, Volume 155, Issue 3, pp. 179 - 192
FLUTICASONE PROPIONATE | INHALED ANTICHOLINERGIC BRONCHODILATOR | SMOKING-CESSATION ADVICE | SALMETEROL/FLUTICASONE PROPIONATE | LUNG-FUNCTION | RANDOMIZED CONTROLLED-TRIAL | MEDICAL HISTORY | OXYGEN-THERAPY | UMCG Approved | HEALTH OUTCOMES | BETA-AGONISTS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Health participants | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Medical History Taking | Pulmonary Disease, Chronic Obstructive - diagnosis | Spirometry | Humans | Pulmonary Disease, Chronic Obstructive - physiopathology | Adrenal Cortex Hormones - therapeutic use | Oxygen Inhalation Therapy | Exercise Therapy | Forced Expiratory Volume | Pulmonary Disease, Chronic Obstructive - therapy | Physical Examination | Adrenergic beta-Agonists - therapeutic use | Drug Therapy, Combination | Cholinergic Antagonists - therapeutic use | Patient Education as Topic | Lung diseases, Obstructive | Care and treatment | Usage | Physicians | Practice guidelines (Medicine) | Diagnosis | Research | Management | Chronic obstructive pulmonary disease | Clinical medicine | Guidelines | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
by Hanania, Nicola A and Sharafkhaneh, Amir and Celli, Bartolome and Decramer, Marc and Lystig, Ted and Kesten, Steven and Tashkin, Donald
Respiratory research, ISSN 1465-9921, 12/2011, Volume 12, Issue 1, pp. 1 - 11
Medicine & Public Health | Pneumology/Respiratory System | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Spirometry | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Forced Expiratory Volume | Time Factors | Albuterol - administration & dosage | Scopolamine Derivatives - administration & dosage | Female | Surveys and Questionnaires | Tiotropium Bromide | Drug Administration Schedule | Proportional Hazards Models | Treatment Outcome | Lung - physiopathology | Ipratropium - administration & dosage | Vital Capacity | Outcome and Process Assessment (Health Care) | Lung - drug effects | Albuterol, Ipratropium Drug Combination | Quality of Life | Aged | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Lung diseases, Obstructive | Patient outcomes | Dosage and administration | Research | Drug therapy | Bronchodilator agents | Decision-making | Prognosis | Ipratropium | Medicine | Statistical methods | Mortality | Quality of life | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Targeting airway inflammation in asthma: Current and future therapies
by Hanania, Nicola A
Chest, ISSN 0012-3692, 2008, Volume 133, Issue 4, pp. 989 - 998
Antiinflammatory therapy | Airway inflammation | IgE | Omalizumab | Inhaled corticosteroids | Steroid-resistant asthma | Asthma | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Pneumonia - etiology | Humans | Antibodies, Monoclonal - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Anti-Allergic Agents - therapeutic use | Antibodies, Monoclonal, Humanized | Pneumonia - drug therapy | Asthma - complications | Anti-Inflammatory Agents - therapeutic use | Adrenergic beta-Agonists - therapeutic use | Antibodies, Anti-Idiotypic | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Epidemiology, management and burden of COPD in the Middle East and North Africa: the BREATHE study
by Hanania, Nicola A
Respiratory medicine, ISSN 0954-6111, 12/2012, Volume 106, pp. S1 - S2
Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Biological and medical sciences | Medical sciences | Pneumology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Response
by Hanania, Alexander N and Hanania, Nicola A
Chest, ISSN 0012-3692, 12/2019, Volume 156, Issue 6, p. 1276
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Lebrikizumab Treatment in Adults with Asthma
by Corren, Jonathan and Lemanske, Robert F and Hanania, Nicola A and Korenblat, Phillip E and Parsey, Merdad V and Arron, Joseph R and Harris, Jeffrey M and Scheerens, Heleen and Wu, Lawren C and Su, Zheng and Mosesova, Sofia and Eisner, Mark D and Bohen, Sean P and Matthews, John G
The New England journal of medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 12, pp. 1088 - 1098
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Cell Adhesion Molecules - blood | Glucocorticoids - therapeutic use | Asthma - physiopathology | Double-Blind Method | Forced Expiratory Volume - drug effects | Interleukin-13 - antagonists & inhibitors | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - adverse effects | Interleukin-13 - immunology | Antibodies, Monoclonal - therapeutic use | Male | Asthma - drug therapy | Asthma - immunology | Adult | Female | Drug Therapy, Combination | Care and treatment | Usage | Causes of | Monoclonal antibodies | Genetic aspects | Health aspects | Asthma | Fees & charges | Phenotypes | Respiratory function | Statistical analysis | Glucocorticoids | Cytokines | Stock options | Clinical trials | Immunoglobulin E | Lymphocytes T | Interleukin 13 | Medical diagnosis | Patients | Manuscripts | Inventors | Product development | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
by Hanania, Nicola A and Noonan, Michael and Corren, Jonathan and Korenblat, Phillip and Zheng, Yanan and Fischer, Saloumeh K and Cheu, Melissa and Putnam, Wendy S and Murray, Elaine and Scheerens, Heleen and Holweg, Cecile TJ and Maciuca, Romeo and Gray, Sarah and Doyle, Ramona and McClintock, Dana and Olsson, Julie and Matthews, John G and Yen, Karl
Thorax, ISSN 0040-6376, 08/2015, Volume 70, Issue 8, pp. 748 - 756
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Asthma - diagnosis | Severity of Illness Index | Asthma - physiopathology | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Lung - physiopathology | Asthma - drug therapy | Dose-Response Relationship, Drug | Forced Expiratory Volume | Young Adult | Time Factors | Antibodies, Monoclonal - administration & dosage | Injections, Subcutaneous | Adolescent | Adult | Female | Aged | Retrospective Studies | Monoclonal antibodies | Clinical trials | Care and treatment | Usage | Dosage and administration | Asthma | Studies | Immunoglobulins | Cytokines | Emergency medical care | Drug dosages | Patients | Index Medicus | Cytokine Biology | Respiratory Research | 1506 | Asthma Mechanisms
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Radiation-Induced Lung Injury Assessment and Management
by Hanania, Alexander N and Mainwaring, Walker and Ghebre, Yohannes T and Hanania, Nicola A and Ludwig, Michelle
Chest, ISSN 0012-3692, 07/2019, Volume 156, Issue 1, pp. 150 - 162
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Pulmonary Fibrosis - therapy | Radiation Pneumonitis - etiology | Humans | Radiation Pneumonitis - physiopathology | Lung Injury - etiology | Radiation Injuries - etiology | Lung Injury - physiopathology | Lung Injury - therapy | Pulmonary Fibrosis - physiopathology | Neoplasms - radiotherapy | Radiation Pneumonitis - therapy | Radiation Injuries - physiopathology | Pulmonary Fibrosis - etiology | Radiation Injuries - therapy | Complications and side effects | Usage | Radiotherapy | Lung diseases | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Omalizumab in severe allergic asthma inadequately controlled with standard therapy: A randomized trial
by Hanania, Nicola A and Alpan, Oral and Hamilos, Daniel L and Condemi, John J and Reyes-Rivera, Irmarie and Zhu, Jin and Rosen, Karin E and Eisner, Mark D and Wong, Dennis A and Busse, William
Annals of internal medicine, ISSN 0003-4819, 2011, Volume 154, Issue 9, pp. 573 - 582
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anti-Asthmatic Agents - adverse effects | Antibodies, Anti-Idiotypic - adverse effects | Prospective Studies | Follow-Up Studies | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Omalizumab | Antibodies, Monoclonal - therapeutic use | Male | Adrenal Cortex Hormones - therapeutic use | Young Adult | Antibodies, Monoclonal, Humanized | Adult | Female | Adrenergic beta-Agonists - therapeutic use | Drug Therapy, Combination |